Saline

0.9% sodium-chloride laboratory diluent · grade and suitability are lot-specific

0.9% NaCl target; verify released-lot result · target, verify batch COACAS 7647-14-5RUO

Research statusEstablished laboratory and pharmacopeial ancillary; offered material remains lot-specific and RUO

Supplied formAqueous sodium chloride solution (laboratory ancillary)

Lead timeConfirmed with quote

Saline — Clear, colorless solution; confirm released-lot appearance

Representative packaging image · verify the ordered lot

Decision summary

Key benefits

Defined 0.9% sodium chloride concentration for compatible laboratory workflows.
Lot qualification can separate composition, osmolality, microbial and endotoxin questions.
PubChem provides an authoritative reference identity for the sodium chloride component.

Published research context is presented for literature orientation only. It is not a dosing, treatment or human-use instruction.

Qualification data

Specifications to confirm against the released lot

CAS: 7647-14-5
Formula: NaCl
Molecular weight: 58.44 g/mol
Appearance: Clear, colorless solution; confirm released-lot appearance
Purity: 0.9% NaCl target; verify released-lot result · target, verify batch COA
Storage: Follow the released-lot label and SDS. Maintain container closure integrity and quarantine material after an unexplained excursion, damaged seal, visible particles or loss of clarity.
MOQ: On request
Lead time: Confirmed with quote

PubChem CID 5234

Qualification matrix

Identity, purity and content are separate release questions.

Identity

Confirm the stated molecule and supplied form. Start with the matching batch COA; request sequence-level evidence only when the buyer's written procedure requires it and availability or a separate scope has been agreed.

Purity

Review RP-HPLC method conditions, wavelength, integration and related-peak handling. A percentage without the method is not enough.

Content

Net peptide content is not the same as gross lyophilized powder weight. Ask which assay supports the stated amount and whether water/counter-ion is addressed.

Stability

Define long-term storage and transit exposure separately. Cold-chain can be quoted when the buyer’s risk assessment requires it and adds cost.

Research context

What researchers study about Saline

This listing is an aqueous 0.9% sodium-chloride laboratory solution, not a peptide or a single pure compound. Sodium chloride has reference formula NaCl and molecular weight 58.44 g/mol. A current 0.9% Sodium Chloride Injection, USP label states 9 mg/mL and calculated osmolarity 308 mOsmol/L for that named finished product; its sterile, nonpyrogenic and clinical status does not transfer to this RUO ancillary. Qualify the offered lot by concentration, pH, osmolality, container and separately specified microbial or endotoxin attributes.

Laboratory diluent and ionic-strength control where method compatibility is established
Ancillary qualification and transport/stability studies

Mechanism context

The question the literature is testing

No pharmacologic mechanism or clinical compatibility is claimed for this RUO ancillary. Its laboratory function is to provide a defined sodium-chloride concentration and ionic-strength context. Suitability must be demonstrated in the exact molecule, formulation, matrix, container and hold-time conditions of the research protocol.

Evidence map

Research routes and exposure context

Evidence tierAnalytical / laboratory context

Research areaLaboratory ancillaries

Routes reported in sources

No administration route applies

Dose / exposure contextProtocol-specific; verify the cited primary source

Routes and exposure contexts summarize cited studies or approved finished-product labels. They are not instructions for administering this RUO material; no customer dose is provided.

Evidence boundaries

Compatibility, limitations and decision context

Do not infer sterility, endotoxin status or suitability from the words '0.9% saline' alone; verify the released-lot result and intended grade.
RUO material is not a finished clinical product.

Interactions reported in the literature

Compatibility is molecule- and method-specific; saline must not be presented as a universal peptide diluent.

Literature context is not a supplier release result or human-use instruction. Follow your institution's approved laboratory risk assessment.

Factory batch documentation

Saline factory batch COAs

No factory batch COA is published for this product yet. Ask sales for the latest available document.

Representative records, refreshed periodically

Published COAs show representative factory batches and may not be the latest available. For a current quote or shipment, our sales team can confirm the applicable lot and provide its COA.

Independent testing, arranged on request

Third-party reports are not routinely published. If independent verification is required, we can agree the laboratory, method, acceptance criteria and remedy before testing. If the agreed specification is not met, an appropriate resolution—including a refund where applicable—can be discussed under the agreed terms. Unless otherwise agreed in writing, the buyer pays the cost of this optional testing.

Help reviewing your COA

Need help reading a factory COA or third-party report? Our sales team can clarify test items, specifications and how the results relate to the lot under discussion.

Ask for the current packet, not a generic certificate

Confirm sodium-chloride concentration or assay, appearance, pH, osmolality, fill volume and container-closure integrity.
Bioburden, sterility, bacterial endotoxin and particulate limits are separate attributes and require agreed methods and released-lot results.
Do not infer injectable grade, clinical compatibility or a universal peptide-diluent claim from the words 0.9% saline.

Released-batch COARP-HPLC result and method contextIdentity result appropriate to the moleculeWater / counter-ion context where relevantSDS and handling statementAdditional testing scoped on request

Handling

Storage in the lab and temperature during transit are different decisions

Follow the released-lot label and SDS. Maintain container closure integrity and quarantine material after an unexplained excursion, damaged seal, visible particles or loss of clarity.

State destination, season, acceptable transit exposure and whether your protocol requires insulated or cold-chain service. Additional temperature-control cost is quoted explicitly.

Buyer FAQ

Terms to settle before the purchase order

Can a buyer arrange third-party testing?+

Yes. Testing must be performed by a mutually accepted, established specialist laboratory. Fee allocation, specification, sampling, method and acceptance rule must be agreed before testing; if an agreed independent result shows nonconformance, the remedy follows the signed order terms. Unless otherwise agreed in writing, the buyer pays the cost of this optional testing.

Does HPLC purity prove peptide content?+

No. Chromatographic purity describes the relative peak profile under a stated method. Identity, water, counter-ion, residual solvents and assay/content may require separate methods.

Is cold-chain shipping always required?+

Not always. Heat can accelerate degradation, especially during summer and long transit. Cold-chain reduces exposure but raises cost. State the destination and stability risk so the right service can be quoted.

How are payment terms handled?+

Available methods and milestones depend on order value, destination and project type. The pro forma invoice should state currency, bank details, fees, payment milestones and the release condition.

Why must the testing laboratory understand peptide chemistry?+

Free-base and salt forms, hydrophilic and hydrophobic sequences, aggregation and adsorption can change sample preparation and method suitability. Use a laboratory experienced with the molecule class.

External qualification references

WHO good storage and distribution practices IATA Temperature Control Regulations ISO/IEC 17025 laboratory competence 21 CFR 211.84 component testing and supplier COA controls

These are buyer-qualification references, not claims that this RUO material is regulated, certified or released under those frameworks. Applicability depends on the buyer's workflow and jurisdiction.

Selected sources

Literature behind the research context

PubChem CID 5234 for sodium chloride reference identity and molecular properties.
Current DailyMed 0.9% Sodium Chloride Injection, USP labels for product-specific 9 mg/mL composition and calculated 308 mOsmol/L context; those labels do not qualify this RUO lot.

01
0.9% Sodium Chloride Injection, USP — current label
DailyMed, U.S. National Library of Medicine · 2025 · official current drug label
Open source
02
Sodium Chloride — PubChem Compound Summary
PubChem, US National Library of Medicine · 2026 · authoritative chemical database
Open source
03
Good storage and distribution practices for medical products
World Health Organization · 2020 · authoritative storage and distribution guidance
Open source

Product FAQ

Questions buyers ask about Saline

Which release data should a buyer request for an RUO saline diluent?+

At minimum, define sodium-chloride concentration or assay, appearance, pH, osmolality, fill volume and container-closure integrity. If the research workflow requires bioburden, sterility, bacterial endotoxin or particulate limits, include each as a separately agreed specification with its method and result. Clear appearance and a 0.9% label cannot establish any of those attributes by themselves.

Saline

Key benefits

Specifications to confirm against the released lot

Identity, purity and content are separate release questions.

What researchers study about Saline

The question the literature is testing

Research routes and exposure context

Compatibility, limitations and decision context

Interactions reported in the literature

Saline factory batch COAs

Ask for the current packet, not a generic certificate

Storage in the lab and temperature during transit are different decisions

Terms to settle before the purchase order

Literature behind the research context

0.9% Sodium Chloride Injection, USP — current label

Sodium Chloride — PubChem Compound Summary

Good storage and distribution practices for medical products

Questions buyers ask about Saline

Compare adjacent molecules and documentation needs.

Bacteriostatic Water

Sterile Water

Acetic Acid Water

Benzyl Alcohol